Related Experiment Videos
[MR tomography following kidney transplantation]
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|November 1, 1987
Summary
Magnetic resonance (MR) tomography can detect reduced corticomedullary contrast (CMC) in renal transplants. This finding may indicate acute tubular necrosis or transplant rejection, prompting early treatment.
Area of Science:
- Nephrology
- Radiology
- Transplant Surgery
Background:
- Renal transplantation is a critical treatment for end-stage renal disease.
- Monitoring graft function post-transplant is essential for patient outcomes.
- Corticomedullary contrast (CMC) on MR imaging may reflect renal health.
Purpose of the Study:
- To evaluate the utility of MR tomography in assessing corticomedullary contrast (CMC) after renal grafting.
- To correlate MR findings with clinical and histological data in transplant patients.
Main Methods:
- MR tomography was performed on 30 patients post-renal transplant.
- Corticomedullary contrast (CMC) was measured.
- MR results were compared with clinical and histological data.
Main Results:
- Normal CMC was observed in 22 patients (73.3%) with normally functioning grafts.
- Eight patients (26.7%) showed reduced CMC (<14%).
- Histological analysis confirmed acute tubular necrosis or transplant rejection in 7 of these 8 patients.
Conclusions:
- Noninvasive MR tomography can provide early indications of acute renal transplant rejection.
- Reduced CMC on MR imaging is a potential marker for graft dysfunction.
- MR tomography can prompt timely intervention for renal transplant complications but cannot differentiate between rejection and acute renal failure.